Woodstock Doctor Sentenced On Drug Distribution Charges
Albany New York--RICHARD S. HARTUNIAN, United States Attorney, Northern District of New York, announces that Dr. WAYNE D. LONGMORE, age 63, of Woodstock, New York, was sentenced on February 7, 2013, in Albany by the Honorable Lawrence E. Kahn, United States District Court Judge, to 6 months home detention, 3 years probation, 200 hours of community service, and ordered to forfeit his New York State medical license, and his DEA license to issue narcotic drugs. In addition to these penalties Dr. Longmore was ordered to pay a $200,000 money judgment which represents proceeds of his drug trafficking activities.
Dr. Longmore previously pled guilty on October 17, 2012, to a felony Information that charged him with knowingly and intentionally distributing and dispensing and possessing with intent to distribute and dispense hydrocodone, a Schedule III controlled substance, without a legitimate medical purpose and outside the usual course of professional practice, contrary to Title 21, United States Code, Sections 841(a)(1) and (b)(1)(E) and Title 21, Code of Federal Regulations, Section 1306.04.
The Plea Agreement states that:
(1) From in or around November 3, 2011, through on or about March 21, 2012, in the Northern District of New York and elsewhere, LONGMORE did knowingly and intentionally distribute and dispense and possess with intent to distribute and dispense hydrocodone, a Schedule III controlled substance, without a legitimate medical purpose and outside the usual course of professional practice.
(2) In order to earn illicit profits from his medical practice, LONGMORE wrote and issued unlawful prescriptions to individuals for drugs containing controlled substances without a legitimate medical purpose and outside the usual course of professional practice.
(3) Longmore wrote these prescriptions in return for $60 cash payments. Longmore would write the illicit prescriptions for only a 7 day period.
(4) Contrary to accepted medical practice, LONGMORE prescribed Schedule III controlled substances to individuals at their first appointment with him and without conducting a thorough